CAMBRIDGE, Mass.--(BUSINESS WIRE)--Parallel Bio, a biotech company pioneering human-first drug discovery, today announced it has raised $21 million Series A funding, led by AIX Ventures. The round ...

VANCOUVER, British Columbia--(BUSINESS WIRE)--Variational AI, the company behind Enki™, an advanced foundation model for small molecule drug discovery, today ...

MOUNTAIN VIEW, CA, UNITED STATES, April 14, 2025 /EINPresswire.com/ -- Highlights: • Obatala Sciences and Ainnocence’s groundbreaking partnership addresses the ...

With support from EDB and A*Star, Japanese biopharma leader Chugai is using its research base in Singapore to create new ...

Javelin, a pioneer in human-centric preclinical drug discovery, today announced the appointment of Robin Robinson, PhD to its Board of Directors, effective February 2025. This strategic addition comes ...

For decades, animal models have been the gold standard for preclinical testing of potential drugs. Yet, even the best animal models are not perfect. For example, small rodent species with engrafted ...

The models can be used to plan surgeries and in the future could be used to help trial new drugs. A healthy heart beats at a steady rate, between 60 and 100 times a minute. That’s not the case for all ...

Liam Taylor, CEO, Axol Bioscience "We have built a unique set of products and services over the last decade to meet the growing requirements from the drug discovery and cosmetic industries to move ...

Deep Human Biology Learning (DHBL) is a unique approach to oncology & neurology research. Through cross-disciplinary collaboration, drug discovery is accelerated, leading to faster development of ...